Published in Br J Clin Pharmacol on August 01, 1998
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science (1986) 5.58
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23
The platelet membrane glycoprotein IIb-IIIa complex. Blood (1988) 4.17
Aspirin as an antiplatelet drug. N Engl J Med (1994) 2.72
CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci U S A (1991) 2.34
GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood (1990) 2.27
Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med (1984) 2.00
Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol (1990) 1.58
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol (1993) 1.22
Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol (1989) 1.14
Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J (1988) 1.14
Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation (1995) 1.13
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation (1984) 1.13
The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost (1995) 1.09
Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol (1990) 1.08
Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J Clin Invest (1995) 1.05
Enhancement of platelet function by superoxide anion. J Clin Invest (1977) 1.04
Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis. Thromb Haemost (1994) 1.03
Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood (1993) 1.02
Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest (1993) 1.01
Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation (1995) 0.98
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest (1987) 0.96
Platelet-neutrophil interactions: their significance. Blood Rev (1992) 0.91
The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid. Br J Clin Pharmacol (1992) 0.91
Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Blood (1991) 0.87
Bidirectional modulation of platelet and polymorphonuclear leukocyte activities. Ann Hematol (1993) 0.86
Antiplatelet drugs and generation of thrombin in clotting blood. Blood (1992) 0.86
Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets. Clin Sci (Lond) (1994) 0.85
Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. Br J Haematol (1991) 0.85
Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood (1994) 0.85
Salicylates: molecular mechanism of therapeutic action. Adv Pharmacol Chemother (1980) 0.84
Platelet activation by polymorphonuclear leukocytes: role of cathepsin G and P-selectin. Thromb Haemost (1995) 0.83
Inhibition of platelet function by polymorphonuclear leukocytes. J Lab Clin Med (1990) 0.81
Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J Lab Clin Med (1990) 0.79
Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem Pharmacol (1993) 0.79
Neutrophils inhibit platelet reactivity by multiple mechanisms: relevance to thromboregulation. J Lab Clin Med (1990) 0.79
Effects of aspirin in arterial thrombosis: why don't animals behave the way humans do? J Am Coll Cardiol (1993) 0.78
Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects. Clin Exp Allergy (1996) 0.78
Platelet aggregation inhibition by mononuclear leukocytes. Thromb Res (1994) 0.77
The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. Br J Clin Pharmacol (1993) 0.77
Differential Expression of Platelet Activation Markers CD62P and CD63 Following Stimulation with PAF, Arachidonic Acid and Collagen. Platelets (1995) 0.76
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06
Effect of encouragement on walking test performance. Thorax (1984) 4.44
Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res (2001) 3.29
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res (2000) 2.79
How should we measure function in patients with chronic heart and lung disease? J Chronic Dis (1985) 2.61
Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation (1995) 2.54
Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest (1999) 2.53
Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol (1995) 2.30
Tissue artefacts caused by sponges. J Clin Pathol (1992) 2.23
Severe late postsplenectomy infection. Br J Surg (1991) 2.15
Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment study (CUDAS). J Am Coll Cardiol (2001) 2.12
Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes. Proteins (2001) 2.08
Platelet and plasma platelet-activating factor in sepsis and myocardial infarction. J Lipid Mediat Cell Signal (1994) 2.07
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Circulation (1999) 1.90
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene (1999) 1.83
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax (2002) 1.80
Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) (1983) 1.79
Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol (1998) 1.73
Presurgical evaluation of patients with epilepsy and normal MRI: role of scalp video-EEG telemetry. J Neurol Neurosurg Psychiatry (1999) 1.59
Unilateral temporal lobectomy patients show lateralized topographical and episodic memory deficits in a virtual town. Brain (2001) 1.57
Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci U S A (1994) 1.56
A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax (2005) 1.55
Nonphotosynthetic retardation of chloroplast senescence by light. Plant Physiol (1969) 1.55
Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol (2001) 1.55
Oxidant stress induces gamma-glutamylcysteine synthetase and glutathione synthesis in human bronchial epithelial NCI-H292 cells. Clin Exp Allergy (2002) 1.55
Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg (1993) 1.54
The biochemistry of common aeroallergens. Clin Exp Allergy (1996) 1.54
Cell salvage at caesarean section: the need for an evidence-based approach. BJOG (2009) 1.51
The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis. J Hum Hypertens (2008) 1.51
Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol (1995) 1.49
Dangers of compound drugs and intravenous aminophylline. Lancet (1982) 1.43
Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis (1984) 1.41
Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis). Thorax (1983) 1.39
Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer (1998) 1.38
Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (2001) 1.35
Anticonvulsant drugs and cognitive functions. Epilepsia (1982) 1.35
Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med (1980) 1.33
Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1. Clin Exp Allergy (2000) 1.30
Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol (1986) 1.29
Epidemiology of chronic venous ulcers. Br J Surg (1991) 1.27
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. Eur Respir J (2000) 1.26
Amygdala pathology in psychosis of epilepsy: A magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain (2002) 1.26
The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy (2001) 1.25
Neural correlates of working memory in Temporal Lobe Epilepsy--an fMRI study. Neuroimage (2012) 1.25
Pharmacokinetics of a single evening dose of slow release theophylline in patients with chronic lung disease. Br J Clin Pharmacol (1981) 1.23
Preoperative fMRI predicts memory decline following anterior temporal lobe resection. J Neurol Neurosurg Psychiatry (2007) 1.22
Addiction to aerosol treatment: the asthmatic alternative to glue sniffing. Br Med J (Clin Res Ed) (1983) 1.20
Material-specific lateralization of memory encoding in the medial temporal lobe: blocked versus event-related design. Neuroimage (2005) 1.20
Prevalence of anal incontinence according to age and gender: a systematic review and meta-regression analysis. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.19
Detection of early lung cancer using low dose Photofrin II. Chest (1990) 1.17
Protease antigens from house dust mite. Lancet (1989) 1.16
Alcoholic drinks: important triggers for asthma. J Allergy Clin Immunol (2000) 1.14
On the potential significance of the enzymatic activity of mite allergens to immunogenicity. Clues to structure and function revealed by molecular characterization. Clin Exp Allergy (1997) 1.13
Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis. Am J Med Genet (2000) 1.12
Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br J Pharmacol (1997) 1.12
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res (2001) 1.11
Frontal lobe function in temporal lobe epilepsy. Epilepsy Res (2011) 1.10
Amyloid and the lower respiratory tract. Thorax (1983) 1.08
Cohabiting with domestic mites. Thorax (1993) 1.07
Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability. Clin Exp Allergy (1998) 1.07
Nutritional status in Malawian patients with pulmonary tuberculosis and response to chemotherapy. Eur J Clin Nutr (1988) 1.07
Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA (1995) 1.07
Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease. Br J Clin Pharmacol (1980) 1.06
Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin Exp Allergy (1996) 1.06
Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala. Brain (2000) 1.06
A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. Oncogene (2010) 1.06
The relationship between quantitative MRI and neuropsychological functioning in temporal lobe epilepsy. Epilepsia (1998) 1.05
Impact of new biomarkers of myocardial damage on trends in myocardial infarction hospital admission rates from population-based administrative data. Am J Epidemiol (2008) 1.05
Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci (2001) 1.04
Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb Symp Quant Biol (1994) 1.04
Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol (1981) 1.03
Tractography of the parahippocampal gyrus and material specific memory impairment in unilateral temporal lobe epilepsy. Neuroimage (2008) 1.03
Categorizing asthma severity. Am J Respir Crit Care Med (1999) 1.02
A specific activity questionnaire to measure the functional capacity of cardiac patients. Am J Cardiol (1996) 1.01
Detection of squamous cell cancer and pre-cancerous lesions by imaging of tissue autofluorescence in the hamster cheek pouch model. Surg Oncol (1992) 1.01
Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRI. J Neurol Neurosurg Psychiatry (2000) 0.99
Class specific inhibition of house dust mite proteinases which cleave cell adhesion, induce cell death and which increase the permeability of lung epithelium. Br J Pharmacol (1998) 0.99
Detection and localization of early lung cancer by imaging techniques. Chest (1991) 0.98
A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol (2001) 0.97
Work related assaults. The impact on victims. AAOHN J (1999) 0.97
The group III allergen from the house dust mite Dermatophagoides pteronyssinus is a trypsin-like enzyme. Immunology (1992) 0.97
The effect of diet upon serum concentrations of theophylline. Br J Clin Pharmacol (1983) 0.97
Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res (1995) 0.97
Imaging language pathways predicts postoperative naming deficits. J Neurol Neurosurg Psychiatry (2007) 0.97
The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res (1993) 0.96
Doctor proactive communication, return-to-work recommendation, and duration of disability after a workers' compensation low back injury. J Occup Environ Med (2001) 0.96
Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis. Thorax (2006) 0.96
Cardiovascular responses to exercise in middle-aged men after 10 days of bedrest. Circulation (1982) 0.96
Faecally derived hydrolytic enzymes from Dermatophagoides pteronyssinus: physicochemical characterisation of potential allergens. Int Arch Allergy Appl Immunol (1991) 0.96
Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3. Neuroscience (2009) 0.95
Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol (1997) 0.95
Does the mode of delivery predispose women to anal incontinence in the first year postpartum? A comparative systematic review. BJOG (2008) 0.95
Disrupted segregation of working memory networks in temporal lobe epilepsy. Neuroimage Clin (2013) 0.93
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93
Mammalian Scratch: a neural-specific Snail family transcriptional repressor. Proc Natl Acad Sci U S A (2001) 0.93